Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Francesca Tosetti, Roberta Venè, Caterina Camodeca, Elisa Nuti, Armando Rossello, Cristina D'Arrigo, Denise Galante, Nicoletta Ferrari, Alessandro Poggi & Maria Raffaella Zocchi. (2018) Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells. OncoImmunology 7:5.
Read now
Read now
Alejandro López-Soto, Segundo Gonzalez & Lorenzo Galluzzi. (2017) Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade. OncoImmunology 6:10.
Read now
Read now
Maria Raffaella Zocchi, Delfina Costa, Roberta Venè, Francesca Tosetti, Nicoletta Ferrari, Simona Minghelli, Roberto Benelli, Stefano Scabini, Emanuele Romairone, Silvia Catellani, Aldo Profumo & Alessandro Poggi. (2017) Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity. OncoImmunology 6:3.
Read now
Read now
Articles from other publishers (31)
Jie-Na Wang & Xiao-Jing Cao. (2023) Targeting ADAM10 in Renal Diseases. Current Molecular Medicine 23:10, pages 1037-1045.
Crossref
Crossref
Léa Rimailho, Carla Faria, Marcin Domagala, Camille Laurent, Christine Bezombes & Mary Poupot. (2023) γδ T cells in immunotherapies for B-cell malignancies. Frontiers in Immunology 14.
Crossref
Crossref
Ting Zhang, Jiayu Wang, Anjing Zhao, Lu Xia, Haiyan Jin, Suhua Xia & Tongguo Shi. (2023) The way of interaction between Vγ9Vδ2 T cells and tumor cells. Cytokine 162, pages 156108.
Crossref
Crossref
Arundhasa Chandrabalan, Andrew Firth, Robert B. Litchfield, C. Thomas Appleton, Alan Getgood & Rithwik Ramachandran. (2023) Human osteoarthritis knee joint synovial fluids cleave and activate Proteinase-Activated Receptor (PAR) mediated signaling. Scientific Reports 13:1.
Crossref
Crossref
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, Kathy Fu, Rory P. Mulloy, Alexandra Phan, Ardeshir Ariana, Corina M. Stewart, Jérémie Prévost, Guillaume Beaudoin-Bussières, Redaet Daniel, Yuxia Bo, Omar El Ferri, Julien Yockell-Lelièvre, William L. Stanford, Patrick M. Giguère, Samira Mubareka, Andrés Finzi, Gregory A. Dekaban, Jimmy D. Dikeakos & Marceline Côté. (2022) Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron. iScience 25:11, pages 105316.
Crossref
Crossref
Yejin Shin, Kang-Sug Jo, Minseok Shin, Duri Lee, Hyejin Yeo, Youngsup Song & Sang-Wook Kang. (2022) Role of redox-sensitive catalytic interaction with ADAM10 in mutant-selective extracellular shedding of prion protein. Redox Biology 56, pages 102456.
Crossref
Crossref
Naike Casagrande, Cinzia Borghese & Donatella Aldinucci. (2022) Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma. Cancers 14:10, pages 2427.
Crossref
Crossref
Alessandro Poggi & Maria Raffaella Zocchi. (2022) Anti-cancer γδ T lymphocytes: contradictory past and promising future. Exploration of Immunology, pages 220-228.
Crossref
Crossref
Roberta Pece, Sara Tavella, Delfina Costa, Serena Varesano, Caterina Camodeca, Doretta Cuffaro, Elisa Nuti, Armando Rossello, Massimo Alfano, Cristina D’Arrigo, Denise Galante, Jean-Louis Ravetti, Marco Gobbi, Francesca Tosetti, Alessandro Poggi & Maria Raffaella Zocchi. (2021) Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect. Haematologica 107:4, pages 909-920.
Crossref
Crossref
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak & Katarzyna Bogunia-Kubik. (2021) NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications. Cells 10:6, pages 1420.
Crossref
Crossref
Leonard H. Calabrese, Roberto Caporali, Christian U. Blank & Allan D. Kirk. (2020) Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer. Journal of Autoimmunity 115, pages 102546.
Crossref
Crossref
Namdoo Kim & Hyuck Jin Lee. (2020) Target Enzymes Considered for the Treatment of Alzheimer’s Disease and Parkinson’s Disease. BioMed Research International 2020, pages 1-14.
Crossref
Crossref
Armando Rossello, Alexander Steinle, Alessandro Poggi & Maria R. Zocchi. (2020) Editorial: ADAM10 in Cancer Immunology and Autoimmunity: More Than a Simple Biochemical Scissor. Frontiers in Immunology 11.
Crossref
Crossref
Maria Raffaella Zocchi, Francesca Tosetti, Roberto Benelli & Alessandro Poggi. (2020) Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy. Cancers 12:7, pages 1886.
Crossref
Crossref
Dmitriy Minond. (2020) Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Timothy M. SmithJr.Jr., Anuj Tharakan & Rebecca K. Martin. (2020) Targeting ADAM10 in Cancer and Autoimmunity. Frontiers in Immunology 11.
Crossref
Crossref
Matthew J. Frank, Niclas Olsson, Andy Huang, Sai-Wen Tang, Robert S. Negrin, Joshua E. Elias & Everett H. Meyer. (2020) A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells. Cytotherapy 22:3, pages 135-143.
Crossref
Crossref
Martin Hart, Barbara Walch-Rückheim, Lena Krammes, Tim Kehl, Stefanie Rheinheimer, Tanja Tänzer, Birgit Glombitza, Martina Sester, Hans-Peter Lenhof, Andreas Keller & Eckart Meese. (2019) miR-34a as hub of T cell regulation networks. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Matyas Meggyes, Eva Miko, Brigitta Szigeti, Nelli Farkas & Laszlo Szereday. (2019) The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface. BMC Pregnancy and Childbirth 19:1.
Crossref
Crossref
Caterina Camodeca, Doretta Cuffaro, Elisa Nuti & Armando Rossello. (2019) ADAM Metalloproteinases as Potential Drug Targets. Current Medicinal Chemistry 26:15, pages 2661-2689.
Crossref
Crossref
Clara Di Vito, Joanna Mikulak, Elisa Zaghi, Silvia Pesce, Emanuela Marcenaro & Domenico Mavilio. (2019) NK cells to cure cancer. Seminars in Immunology 41, pages 101272.
Crossref
Crossref
Bart N. Lambrecht, Matthias Vanderkerken & Hamida Hammad. (2018) The emerging role of ADAM metalloproteinases in immunity. Nature Reviews Immunology 18:12, pages 745-758.
Crossref
Crossref
Caterina Camodeca, Elisa Nuti, Francesca Tosetti, Alessandro Poggi, Cristina D'Arrigo, Maria Raffaella Zocchi & Armando Rossello. (2018) Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes. ChemMedChem 13:19, pages 2119-2131.
Crossref
Crossref
Dominik Schmiedel & Ofer Mandelboim. (2018) NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy. Frontiers in Immunology 9.
Crossref
Crossref
Tobias Brummer, Martina Pigoni, Armando Rossello, Huanhuan Wang, Peter J. Noy, Michael G. Tomlinson, Carl P. Blobel & Stefan F. Lichtenthaler. (2018) The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation. The FASEB Journal 32:7, pages 3560-3573.
Crossref
Crossref
Bastian Dörsam, Teresa Bösl, Katrin S. Reiners, Sabine Barnert, Rolf Schubert, Olga Shatnyeva, Paola Zigrino, Andreas Engert, Hinrich P. Hansen & Elke Pogge von Strandmann. (2018) Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype. Frontiers in Immunology 9.
Crossref
Crossref
Delfina Costa, Roberta Venè, Roberto Benelli, Emanuele Romairone, Stefano Scabini, Silvia Catellani, Barbara Rebesco, Luca Mastracci, Federica Grillo, Simona Minghelli, Fabrizio Loiacono, Maria Raffaella Zocchi & Alessandro Poggi. (2018) Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts. Frontiers in Immunology 9.
Crossref
Crossref
Alessandro Poggi, Serena Varesano & Maria Raffaella Zocchi. (2018) How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Frontiers in Immunology 9.
Crossref
Crossref
Sabrina Amar, Dmitriy Minond & Gregg B. Fields. (2017) Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases. PROTEOMICS 17:23-24, pages 1600389.
Crossref
Crossref
Sebastian Wetzel, Lisa Seipold & Paul Saftig. (2017) The metalloproteinase ADAM10: A useful therapeutic target?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:11, pages 2071-2081.
Crossref
Crossref
Alessandro Poggi & Massimo Giuliani. (2016) Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment. Vaccines 4:4, pages 41.
Crossref
Crossref